Trial Profile
Effects of Rifaximin Treatment in Patients With Acute Alcoholic Hepatitis: A Comparative Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary) ; Prednisone; Prednisone
- Indications Alcoholic hepatitis
- Focus Therapeutic Use
- Acronyms RIFA-AH
- 01 May 2022 Results published in the Liver International
- 01 May 2022 Status changed to completed, as per results published in the Liver International
- 03 Nov 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016.